Canada markets closed

Elevation Oncology, Inc. (ELEV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6200-0.0250 (-0.69%)
At close: 04:00PM EDT
3.6200 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 176.12M
Enterprise Value 123.15M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.21
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.97

Trading Information

Stock Price History

Beta (5Y Monthly) 1.36
52-Week Change 318.30%
S&P500 52-Week Change 322.36%
52 Week High 35.8900
52 Week Low 30.3630
50-Day Moving Average 34.2327
200-Day Moving Average 31.8659

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 3679.25k
Shares Outstanding 548.65M
Implied Shares Outstanding 654.17M
Float 819.16M
% Held by Insiders 11.97%
% Held by Institutions 186.43%
Shares Short (Apr 15, 2024) 44.95M
Short Ratio (Apr 15, 2024) 45.76
Short % of Float (Apr 15, 2024) 411.32%
Short % of Shares Outstanding (Apr 15, 2024) 410.18%
Shares Short (prior month Mar 15, 2024) 44.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.52%
Return on Equity (ttm)-88.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -40.3M
Net Income Avi to Common (ttm)-45.7M
Diluted EPS (ttm)-1.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)83.11M
Total Cash Per Share (mrq)1.71
Total Debt (mrq)30.14M
Total Debt/Equity (mrq)54.98%
Current Ratio (mrq)21.22
Book Value Per Share (mrq)1.29

Cash Flow Statement

Operating Cash Flow (ttm)-56.18M
Levered Free Cash Flow (ttm)-38.17M